Bionovo completes 13 weeks repeat dose animal toxicology studies for Menerba
 

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today the successful completion of 13 weeks repeat dose animal toxicology studies with Menerba.

More...